Immune Systems Advisor

A laboratory worker at an anti-plague research institute in Siberia died after developing severe pneumonia. Russian authorities have not confirmed plague , while conflicting reports have fueled concern about a possible pneumonic-plague infection or laboratory exposure. Updated: October 6, 2026   |   Status: Developing story Important: There is no confirmed evidence, as of October 6, 2026, that a pneumonic-plague outbreak is occurring in Siberia. Russia's federal public-health watchdog, Rospotrebnadzor, has described the patient's illness as pneumonia of unknown etiology and said expanded testing did not identify microorganisms associated with her professional activity. The World Health Organization has said that, based on available information, the public-health risk to the general population appears low. What happened in Irkutsk? A 28-year-old employee identified by local and international reporting as Da...

Medically reviewed by Editorial Team | Last updated: July 21, 2026 Quick Answer Cyclosporiasis is a diarrheal illness caused by the parasite Cyclospora cayetanensis , usually picked up from contaminated fresh produce. A large 2026 outbreak has pushed Michigan's case count past 6,000 (102 hospitalized), with additional cases confirmed in states including Ohio, New York, and Texas. The source of contamination has been traced to a lettuce supplier in Mexico. Most healthy people recover, and the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX) is the CDC's recommended treatment. A fast-moving outbreak of cyclosporiasis — an intestinal infection caused by a microscopic parasite typically carried on fresh produce — has become one of the largest seen in the United States in years. Michigan has borne the brunt of it, but health departments in several other states are reporting cases as investigators work to trace the contamination back to its source. FDA managed to trace con...

Quick Answer A 2026 real-world survey of 506 verified purchasers of The Wellness Company's eight-medication Medical Emergency Kit found that 71.9% used the kit at least once, 81.6% reported meaningful improvement within three days of use, and 95.8% reported some form of net benefit. Only 2.4% reported side effects, all mild. The study is a preprint posted on Zenodo — not yet peer-reviewed — built entirely on self-reported data with no control group, and all 11 authors are affiliated with or compensated by the company selling the kit. It should be read as hypothesis-generating, not proof of clinical effectiveness. Key Takeaways The first real-world data on pre-prescribed emergency medication kits comes from a 506-respondent survey , posted as a Zenodo preprint on June 23, 2026 — it has not been peer-reviewed. 71.9% of purchasers used their kit at least once; 28.3% used it three or more times. Respiratory illness was the leading reason for use (59.4% of e...